AAAAAA

   
Results: 1-10 |
Results: 10
Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells
Authors: Burrows, GG Chou, YK Wang, CH Chang, JW Finn, TP Culbertson, NE Kim, J Bourdette, DN Lewinsohn, DA Lewinsohn, DM Ikeda, M Yoshioka, T Allen, CN Offner, H Vandenbark, AA
Citation: Gg. Burrows et al., Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells, J IMMUNOL, 167(8), 2001, pp. 4386-4395
T lymphocytes promote the development of bone marrow-derived APC in the central nervous system
Authors: Subramanian, S Bourdette, DN Corless, C Vandenbark, AA Offner, H Jones, RE
Citation: S. Subramanian et al., T lymphocytes promote the development of bone marrow-derived APC in the central nervous system, J IMMUNOL, 166(1), 2001, pp. 370-376
Differential susceptibility of human T(h)1 versus T(h)2 cells to inductionof anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cells
Authors: Vandenbark, AA Barnes, D Finn, T Bourdette, DN Whitham, R Robey, I Kaleeba, J Bebo, BF Miller, SD Offner, H Chou, YK
Citation: Aa. Vandenbark et al., Differential susceptibility of human T(h)1 versus T(h)2 cells to inductionof anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cells, INT IMMUNOL, 12(1), 2000, pp. 57-66
Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis
Authors: Fischer, JS Priore, RL Jacobs, LD Cookfair, DL Rudick, RA Herndon, RM Richert, JR Salazar, AM Goodkin, DE Granger, CV Simon, JH Grafman, JH Lezak, MD Hovey, KMO Perkins, KK Barilla-Clark, D Schacter, M Shucard, DW Davidson, AL Wende, KE Bourdette, DN Kooijmans-Coutinho, MF
Citation: Js. Fischer et al., Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis, ANN NEUROL, 48(6), 2000, pp. 885-892
Design, engineering and production of functional single-chain T-cell receptor ligands
Authors: Burrows, GG Chang, JW Bachinger, HP Bourdette, DN Offner, H Vandenbank, AA
Citation: Gg. Burrows et al., Design, engineering and production of functional single-chain T-cell receptor ligands, PROTEIN ENG, 12(9), 1999, pp. 771-778
IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R alpha and gamma chains
Authors: Chou, YK Bourdette, DN Barnes, D Finn, TP Murray, S Unsicker, L Robey, I Whitham, RH Buenafe, AC Allegretta, M Offner, H Vandenbark, AA
Citation: Yk. Chou et al., IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R alpha and gamma chains, J NEUROIMM, 96(1), 1999, pp. 101-111
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis
Authors: Rudick, RA Cookfair, DL Simonian, NA Ransohoff, RM Richert, JR Jacobs, LD Herndon, RM Salazar, AM Fischer, JS Granger, CV Goodkin, DE Simon, JH Bartoszak, DM Bourdette, DN Braiman, J Brownscheidle, CM Coats, ME Cohan, SL Dougherty, DS Kinkel, RP Mass, MK Munchsauer, FE O'Reilly, K Priore, RL Pullicino, PM Scherokman, BJ Wende, K Weinstock-Guttman, B Whitham, RH
Citation: Ra. Rudick et al., Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis, J NEUROIMM, 93(1-2), 1999, pp. 8-14
Myelin basic protein-specific T lymphocytes induce chronic relapsing experimental autoimmune encephalomyelitis in lymphocyte-deficient (SCID) mice
Authors: Jones, RE Mass, M Bourdette, DN
Citation: Re. Jones et al., Myelin basic protein-specific T lymphocytes induce chronic relapsing experimental autoimmune encephalomyelitis in lymphocyte-deficient (SCID) mice, J NEUROIMM, 93(1-2), 1999, pp. 92-101
Gulf War unexplained illnesses: Persistence and unexplained nature of self-reported symptoms
Authors: McCauley, LA Joos, SK Lasarev, MR Storzbach, D Bourdette, DN
Citation: La. Mccauley et al., Gulf War unexplained illnesses: Persistence and unexplained nature of self-reported symptoms, ENVIR RES, 81(3), 1999, pp. 215-223
Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials
Authors: Goodkin, DE Priore, RL Wende, KE Campion, M Bourdette, DN Herndon, RM Fischer, JS Jacobs, LD Cookfair, DL Rudick, RA Richert, JR Salazar, AM Granger, CV Simon, JH Alam, JJ Bartoszak, DM Braiman, J Brownscheidle, CM Coats, ME Cohan, SL Dougherty, DS Kinkel, RP Mass, MK Munschauer, FE Pullicino, PM Scherokman, BJ Weinstock-Guttman, B Whitham, RH
Citation: De. Goodkin et al., Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials, MULT SCLER, 4(6), 1998, pp. 480-486
Risultati: 1-10 |